GC
UPI

Guggenheim Capital’s UROPLASTY INC-NEW UPI Stock Holding History

Guggenheim Capital’s Portfolio UPI Stock Details UPI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-12,571
Closed -$34K – 3256
2014
Q2 		$34K Sell
12,571
-1,256
-9% -$3.94K ﹤0.01% 3121
2014
Q1 		$50K Buy
13,827
+3,142
+29% +$12.3K ﹤0.01% 3133
2013
Q4 		$29K Buy
10,685
+634
+6% +$1.93K ﹤0.01% 3105
2013
Q3 		$33K Hold
10,051
– – ﹤0.01% 2984
2013
Q2 		$21K Buy
+10,051
New +$23K ﹤0.01% 2984

Other funds holding UPI

Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
CAM
Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return
MHP
Manatuck Hill Partners Westport, Connecticut $370M AUM 95.53% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
AC
Amici Capital New York $257M AUM 4.88% 1-Year Est. Return
RCP
Rothschild Capital Partners New York $408M AUM 25.87% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return

Guggenheim Capital's UPI Position: Q3 2014 in Review

Guggenheim Capital sold out of UROPLASTY INC-NEW (UPI) in Q3 2014, closing a stake of 12,571 shares — an estimated $34K sold.

Guggenheim Capital first reported a position in UPI in Q2 2013 and held it in 5 quarters. The position peaked at $50K in Q1 2014. 31 funds tracked by Wall St. Rank hold UPI as of Q3 2014.

  • Guggenheim Capital reported no remaining UROPLASTY INC-NEW position as of Q3 2014 after selling out during the quarter.
  • Guggenheim Capital sold 12,571 UROPLASTY INC-NEW shares in Q3 2014, an estimated $34K.
  • Guggenheim Capital first reported a position in UROPLASTY INC-NEW in Q2 2013 and held it in 5 quarters.
  • Guggenheim Capital's UROPLASTY INC-NEW position peaked at $50K in Q1 2014.
  • 31 funds tracked by Wall St. Rank held UROPLASTY INC-NEW as of Q3 2014.

Based on Guggenheim Capital's 13F filing for Q3 2014, filed 14 Nov 2014.